Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28,463 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immune checkpoint inhibitor-related adverse events in lung cancer: Real-world incidence and management practices of 1905 patients in China.
Shi Y, Fang J, Zhou C, Liu A, Wang Y, Meng Q, Ding C, Ai B, Gu Y, Yao Y, Sun H, Guo H, Zhang C, Song X, Li J, Xu B, Han Z, Song M, Tang T, Chen P, Lu H, Shui Y, Lou G, Zhang D, Liu J, Liu X, Liu X, Gao X, Zhou Q, Chen M, Zhao J, Zhong W, Xu Y, Wang M. Shi Y, et al. Among authors: gao x. Thorac Cancer. 2022 Feb;13(3):412-422. doi: 10.1111/1759-7714.14274. Epub 2021 Dec 21. Thorac Cancer. 2022. PMID: 34935288 Free PMC article.
[Clinical-radiological-pathological Characteristics of 297 Cases of Surgical Pathology Confirmed Benign Pulmonary Lesions in Which Malignancy Could Not Be Excluded in Preoperative Assessment: A Retrospective Cohort Analysis in a Single Chinese Hospital].
Liu Y, Chen M, Guo C, Zhong W, Ye Q, Zhao J, Zhou Q, Gao X, Liu X, Liang H, Shi Y, Jiang D, Liu H, Xu Y, Li S, Wang M. Liu Y, et al. Among authors: gao x. Zhongguo Fei Ai Za Zhi. 2020 Sep 20;23(9):792-799. doi: 10.3779/j.issn.1009-3419.2020.104.24. Epub 2020 Aug 10. Zhongguo Fei Ai Za Zhi. 2020. PMID: 32773007 Free PMC article. Chinese.
Correlations between peripheral blood biomarkers and clinical outcomes in advanced non-small cell lung cancer patients who received immunotherapy-based treatments.
Shi Y, Liu X, Liu J, Zhang D, Liu X, Yue Y, Zhou Q, Gao X, Chen M, Xu Y, Zhao J, Zhong W, Provencio M, Jassem J, Williams TM, Seeber A, Kocher F, Wang M. Shi Y, et al. Among authors: gao x. Transl Lung Cancer Res. 2021 Dec;10(12):4477-4493. doi: 10.21037/tlcr-21-710. Transl Lung Cancer Res. 2021. PMID: 35070755 Free PMC article.
The development of a tumor-associated autoantibodies panel to predict clinical outcomes for immune checkpoint inhibitor-based treatment in patients with advanced non-small-cell lung cancer.
Zhao J, Wu Y, Yue Y, Chen M, Xu Y, Liu X, Liu X, Gao X, Wang H, Si X, Zhong W, Zhang X, Zhang L, Wang M. Zhao J, et al. Among authors: gao x. Thorac Cancer. 2023 Feb;14(5):497-505. doi: 10.1111/1759-7714.14772. Epub 2023 Jan 2. Thorac Cancer. 2023. PMID: 36594104 Free PMC article.
Study protocol of KeyPemls-004: A phase 2 study of pembrolizumab in combination with plinabulin and docetaxel in previously treated patients with metastatic non-small cell lung cancer and progressive disease (PD) after immunotherapy (PD-1/PD-L1 inhibitor) alone or in combination with platinum-doublet chemotherapy.
Liu J, Chen M, Gao X, Liu X, Zhao J, Pan R, Zhong W, Xu Y, Wang M. Liu J, et al. Among authors: gao x. Thorac Cancer. 2023 Mar;14(8):773-778. doi: 10.1111/1759-7714.14806. Epub 2023 Feb 1. Thorac Cancer. 2023. PMID: 36725772 Free PMC article.
28,463 results
You have reached the last available page of results. Please see the User Guide for more information.